These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10649740)

  • 1. Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.
    Fassinger N; Dabbagh S; Mukhopadhyay S; Lee DY
    Adv Perit Dial; 1998; 14():274-7. PubMed ID: 10649740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of ion exchange resins on the composition of milk].
    Bonnet L; Goudable J; Accominotti M; Fontaine D; Cochat P
    Nephrologie; 1997; 18(7):287-9. PubMed ID: 9496569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
    Rivard AL; Raup SM; Beilman GJ
    JPEN J Parenter Enteral Nutr; 2004; 28(2):76-8. PubMed ID: 15080600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional management of hyperkalemic infants with chronic kidney disease, using adult renal formulas.
    Hobbs DJ; Gast TR; Ferguson KB; Bunchman TE; Barletta GM
    J Ren Nutr; 2010 Mar; 20(2):121-6. PubMed ID: 19853475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.
    Bennett LN; Myers TF; Lambert GH
    Am J Perinatol; 1996 Apr; 13(3):167-70. PubMed ID: 8688109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.
    Bunchman TE; Wood EG; Schenck MH; Weaver KA; Klein BL; Lynch RE
    Pediatr Nephrol; 1991 Jan; 5(1):29-32. PubMed ID: 2025533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K; Cazee C; Gutch C; Ogden D
    Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate.
    Schröder CH; van den Berg AM; Willems JL; Monnens LA
    Eur J Pediatr; 1993 Mar; 152(3):263-4. PubMed ID: 8444258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium, magnesium, sodium, potassium and iron content of infant formulas and estimated daily intakes.
    Ruiz MC; Alegría A; Barberá R; Farré R; Lagarda MJ
    J Trace Elem Med Biol; 1996 Apr; 10(1):25-30. PubMed ID: 8793820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J
    Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on renal net acid excretion of various mineral contents in three lots of a common pre-term formula.
    Tölle HG; Manz F; Diekmann L; Kalhoff H; Stock GJ
    J Trace Elem Electrolytes Health Dis; 1991 Dec; 5(4):235-8. PubMed ID: 1822331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulas for premature infants: fate of the calcium and phosphorus.
    Bhatia J; Fomon SJ
    Pediatrics; 1983 Jul; 72(1):37-40. PubMed ID: 6408594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyperkalemia in hospitalized patients.
    Fordjour KN; Walton T; Doran JJ
    Am J Med Sci; 2014 Feb; 347(2):93-100. PubMed ID: 23255245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infant formula with patiromer dose dependently decreases potassium concentration.
    Paloian NJ; Bowman B; Bartosh SM
    Pediatr Nephrol; 2019 Aug; 34(8):1395-1401. PubMed ID: 30963285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal formulas pretreated with medications alters the nutrient profile.
    Taylor JM; Oladitan L; Carlson S; Hamilton-Reeves JM
    Pediatr Nephrol; 2015 Oct; 30(10):1815-23. PubMed ID: 25930981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dephytinization and follow-on formula addition on in vitro iron, calcium, and zinc availability from infant cereals.
    Frontela C; Haro JF; Ros G; Martínez C
    J Agric Food Chem; 2008 May; 56(10):3805-11. PubMed ID: 18433137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The in vitro effect of the addition of ion exchange resins on the bioavailability of electrolytes in artificial enteral feeding formulas].
    Martí Bonmati E; Tomas Bondia F; Milara J; Cortijo J
    Farm Hosp; 2008; 32(2):91-5. PubMed ID: 18783708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium polystyrene sulfonate (kayexalate) aspiration: histologic appearance and infrared microspectrophotometric analysis of two cases.
    Fenton JJ; Johnson FB; Przygodzk RM; Kalasinsky VF; Al-Dayel F; Travis WD
    Arch Pathol Lab Med; 1996 Oct; 120(10):967-9. PubMed ID: 12046610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.